The company has demonstrably advanced the development of an innovative therapy for amyloid heart disease, employing Attruby. Initial patient results suggests promising outcomes for those affected from a severe illness. https://bridgebio260232.bloggactivo.com/41163498/company-progresses-amyloidosis-treatment-through-the-drug